Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Acute Kidney Injury Due to Sepsis: early-phase trial registry
2 of 3 indexed Acute Kidney Injury Due to Sepsis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Acute Kidney Injury Due to Sepsis: 3 US clinical trials tracked, 2 recruiting.
Acute Kidney Injury Due to Sepsis is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is SeaStar Medical, running 1 of these trials.
Enrollment posture brief
Registry condition acute-kidney-injury-due-to-sepsis
OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Acute Kidney Injury Due to Sepsis lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Acute Kidney Injury Due to Sepsis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Acute Kidney Injury Due to Sepsis is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
SeaStar Medical
NCT06517810
Renin Angiotensin Aldosterone System In Septic Kids
Northwell Health
NCT06295393
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)
Novartis Pharmaceuticals
NCT05996835
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Acute Kidney Injury Due to Sepsis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Acute Kidney Injury Due to Sepsis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Acute Kidney Injury Due to Sepsis page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Acute Kidney Injury Due to Sepsis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- SeaStar Medical sponsors the most Acute Kidney Injury Due to Sepsis trials on record, review their full trial history before evaluating a specific study. See SeaStar Medical's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Kidney Injury Due to Sepsis condition card totals 3 registered trials; most-linked intervention TIN816 70 mg lyophilisate powder; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.